Logo image of NAVA.OL

NAVAMEDIC (NAVA.OL) Stock Overview

OSL:NAVA - NO0010205966 - Common Stock

21.6 NOK
-0.2 (-0.92%)
Last: 9/9/2025, 7:00:00 PM

NAVA.OL Key Statistics, Chart & Performance

Key Statistics
52 Week High32
52 Week Low17.1
Market Cap512.14M
Shares23.71M
Float14.77M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.71
PEN/A
Fwd PE15.92
Earnings (Next)N/A N/A
IPO03-31 2006-03-31
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


NAVA.OL short term performance overview.The bars show the price performance of NAVA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

NAVA.OL long term performance overview.The bars show the price performance of NAVA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of NAVA.OL is 21.6 NOK. In the past month the price decreased by -14.29%. In the past year, price decreased by -25.26%.

NAVAMEDIC / NAVA Daily stock chart

NAVA.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 46.52 605.45B
1LLY.MI ELI LILLY & CO 44.82 583.30B
ZEG.DE ASTRAZENECA PLC 18.39 428.80B
1JNJ.MI JOHNSON & JOHNSON 17.86 365.97B
JNJ.DE JOHNSON & JOHNSON 17.51 358.94B
RHO.DE ROCHE HOLDING AG-BR 14.49 247.14B
NOT.DE NOVARTIS AG-REG 14.7 211.67B
NOV.DE NOVO NORDISK A/S-B 13.98 207.44B
1SAN.MI SANOFI 10.75 198.04B
SNW.DE SANOFI 10.7 196.95B
SAN.PA SANOFI 10.63 195.80B
6MK.DE MERCK & CO. INC. 10.88 178.34B

About NAVA.OL

Company Profile

NAVA logo image Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 42 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.

Company Info

NAVAMEDIC

Henrik Ibsens gate 100

Oslo OSLO NO

Employees: 45

NAVA Company Website

NAVA Investor Relations

Phone: 4767112540

NAVAMEDIC / NAVA.OL FAQ

What is the stock price of NAVAMEDIC today?

The current stock price of NAVA.OL is 21.6 NOK. The price decreased by -0.92% in the last trading session.


What is the ticker symbol for NAVAMEDIC stock?

The exchange symbol of NAVAMEDIC is NAVA and it is listed on the Euronext Oslo exchange.


On which exchange is NAVA.OL stock listed?

NAVA.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for NAVAMEDIC stock?

7 analysts have analysed NAVA.OL and the average price target is 40.8 NOK. This implies a price increase of 88.89% is expected in the next year compared to the current price of 21.6. Check the NAVAMEDIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NAVAMEDIC worth?

NAVAMEDIC (NAVA.OL) has a market capitalization of 512.14M NOK. This makes NAVA.OL a Small Cap stock.


How many employees does NAVAMEDIC have?

NAVAMEDIC (NAVA.OL) currently has 45 employees.


What are the support and resistance levels for NAVAMEDIC (NAVA.OL) stock?

NAVAMEDIC (NAVA.OL) has a support level at 21.5 and a resistance level at 21.61. Check the full technical report for a detailed analysis of NAVA.OL support and resistance levels.


Is NAVAMEDIC (NAVA.OL) expected to grow?

The Revenue of NAVAMEDIC (NAVA.OL) is expected to grow by 12.65% in the next year. Check the estimates tab for more information on the NAVA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NAVAMEDIC (NAVA.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NAVAMEDIC (NAVA.OL) stock pay dividends?

NAVA.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of NAVAMEDIC (NAVA.OL)?

NAVAMEDIC (NAVA.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.71).


NAVA.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

NAVA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NAVA.OL. The financial health of NAVA.OL is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NAVA.OL Financial Highlights

Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS decreased by -5.58% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.17%
ROE -2.53%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%-364.67%
Sales Q2Q%9.23%
EPS 1Y (TTM)-5.58%
Revenue 1Y (TTM)6.15%

NAVA.OL Forecast & Estimates

7 analysts have analysed NAVA.OL and the average price target is 40.8 NOK. This implies a price increase of 88.89% is expected in the next year compared to the current price of 21.6.

For the next year, analysts expect an EPS growth of -81.87% and a revenue growth 12.65% for NAVA.OL


Analysts
Analysts82.86
Price Target40.8 (88.89%)
EPS Next Y-81.87%
Revenue Next Year12.65%

NAVA.OL Ownership

Ownership
Inst Owners32.09%
Ins Owners16.59%
Short Float %N/A
Short RatioN/A